(2S)-2-((tert-Butoxycarbonyl)amino)-2-(3-hydroxyadamantan-1-yl)acetic acid

We are (2S)-2-((tert-Butoxycarbonyl)amino)-2-(3-hydroxyadamantan-1-yl)acetic acid CAS:361442-00-4 manufacturer and supplier in China, Pls send inquiry of to info@nbinno.com of visit www.nbinno.com our official website should you have any interests

Chemical Name: (2S)-2-((tert-Butoxycarbonyl)amino)-2-(3-hydroxyadamantan-1-yl)acetic acid
CAS.NO:361442-00-4
Synonyms:
BOC-L-SERINE T-BUTYLESTER
Boc-3-Hydroxy-1-adamantyl-D-glycine
Boc-L-Serine tert.butyl ester
(S)-N-Boc-3-hydroxyadamantylglycine
Boc-Ser-Otbu

Molecular Formula:C17H27NO5
Molecular Weight: 325.40000

Physical and Chemical Properties:
Density:1.296g/cm3
Boiling point: 497.253ºC at 760 mmHg
Melting point: /
Flash point:225.4±23.2 °C
Refractive index: 1.540

Specification:
Appearance: White to off-white crystalline powder
Purity:≥98%
Water:≤0.5%
Residue on ignition:≤0.5%
Loss on drying:≤0.5%

Packing:
 25kg  cardboard drum or according to customer specified requirements
Storage:Stored in a cool and dry well-closed container. Keep away from moisture and strong light/heat.
Application:Intermediates of Saxagliptin CAS:361442-04-8
Intermediates of Saxagliptin hydrochloride CAS:709031-78-7

Related News: However, pharmaceutical intermediates are subdivided into primary intermediates and advanced intermediates. Because primary intermediate suppliers can only provide simple intermediate production, they are at the front end of the industrial chain. The pressure of competition and price is the greatest. The price fluctuations of basic chemical raw materials have a greater impact on them.methyl 3-aminothiophene-2-carboxylate CAS:22288-78-4 The CTSuccess service uses Catalent’s proprietary StartScoreTM evaluation tool to calculate the complexity of a potential clinical project across more than a dozen specific and objective study characteristics.333717-40-1 The Company selected the top-performing clone for generation of the master engineered iPSC bank for GMP production of FT819.bisphenol AF Cost: Hedge prices of thick product lines + self-produced intermediates fluctuate, and sufficient supply of upstream raw materials can significantly promote the production of APIs.Since the listing of high-barrier generic drugs involves quickly bypassing or challenging process patents of original research products within a short period of time, API companies play an important role in the process of marketing and sales of generic drugs.